Supernus Pharmaceuticals Inc (SUPN) — Capital Reinvestment Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($19.86 Million) in capital expenditures ($427.00K). See Supernus Pharmaceuticals Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Supernus Pharmaceuticals Inc Capital Reinvestment Ratio (2009–2025)
This chart tracks Supernus Pharmaceuticals Inc's Capital Reinvestment Ratio across 13 annual periods. Check Supernus Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Supernus Pharmaceuticals Inc (2009–2025)
Year-by-year Capital Reinvestment Ratio for Supernus Pharmaceuticals Inc from 2009 to 2025. For live market cap and broader valuation context, see SUPN market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $47.33 Million | $1.34 Million | ▲ +570.5% |
| 2024 | 0.00x | $171.95 Million | $725.00K | ▼ -15.0% |
| 2023 | 0.00x | $111.08 Million | $551.00K | ▲ +40.6% |
| 2022 | 0.00x | $116.83 Million | $412.00K | ▼ -78.1% |
| 2021 | 0.02x | $127.13 Million | $2.04 Million | ▼ -35.5% |
| 2020 | 0.02x | $138.40 Million | $3.45 Million | ▲ +30.4% |
| 2019 | 0.02x | $143.13 Million | $2.74 Million | ▲ +192.1% |
| 2018 | 0.01x | $128.99 Million | $844.00K | ▼ -63.0% |
| 2017 | 0.02x | $114.64 Million | $2.03 Million | ▼ -26.2% |
| 2016 | 0.02x | $66.81 Million | $1.60 Million | ▼ -63.4% |
| 2015 | 0.07x | $32.12 Million | $2.10 Million | ▼ -14.6% |
| 2014 | 0.08x | $7.73 Million | $593.00K | ▼ -71.7% |
| 2009 | 0.27x | $2.63 Million | $714.00K | — |